Investor insights
Sectors invested in
Biotechnology3
Product Research2
Pharmaceutical1
NASH1
알레르기1
신약 개발1
Immuno-Oncology1
단백질 신약1
항암1
바이오제약1
Life Science1
Genome Engineering1
Therapeutics1
Genetics1
CRISPR1
Cancer1
Drug Development1
Antibody1
Biopharmaceutical1
Monoclonal antibodies1
Funding rounds participated in
$54M sweet spot round size
Most of their 4 investments are in rounds between $24M and $54M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Long-acting Fc fusion protein: hyFc platform
Health Care
Therapeutic DNA vaccines in Oncology
Medical
Innovative Bio medicine
Life Science
Date founded
1999
Investments made
U
Undisclosed raised $24M on February 24, 2022
Investors: DS Asset Management, Korea Omega Investment Corp., Smilegate Investment, DAYLI Partners, Mirae Asset Securities (USA) Inc., CJ HealthCare Corp. and Genexine, Inc.
G
GI Innovation raised $54M on April 12, 2021
Investors: Samsung iMarketKorea Inc and Genexine, Inc.
T
ToolGen Inc. raised undisclosed on December 14, 2020
Investors: Genexine, Inc.
I
I-Mab Biopharma raised $150M on March 23, 2017
Investors: Tasly Pharmaceutical Group Co., LTD. and Genexine, Inc.
Funding rounds raised
G
Genexine, Inc. raised undisclosed on January 1, 2006
Investors: IMM Private Equity